Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03650101 · ClinicalTrials.gov registry record

Improving Infant Hydrocephalus Outcomes in Uganda

A clinical trial of Hydrocephalus, sponsored by Boston Children's Hospital.

Active
Registry status
400
Enrollment target
3
Study locations

NCT03650101 is a study of Hydrocephalus that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 400 participants, above the 110-participant average among 17 other Hydrocephalus trials with a reported enrollment target (264% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03650101, a study of Hydrocephalus, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
400 participants
Enrollment target
3
Study locations

Study Summary

Neonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC) is an alternate treatment to give patients a shunt-free life. In this study, the investigators aim to optimize the metrics of evaluation as quantitative prognostic indicators of treatment response and long term outcomes.

Conditions Studied

Hydrocephalus

Interventions

  • PROCEDURE ETV/CPC

Study Locations (3)

Pennsylvania

  • Penn State University - University Park

Ontario

  • The Hospital for Sick Children - Toronto

Other

  • Cure Children's Hospital of Uganda - Mbale

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-05-05
Est. Completion 2027-12

Sponsor

Boston Children's Hospital

462 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03650101

The ClinicalTrials.gov registry entry for NCT03650101 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 17 other Hydrocephalus trials with a reported enrollment target (264% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which ETV/CPC is the first listed.

NCT03650101 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Ontario, Other.

Frequently Asked Questions

What is clinical trial NCT03650101 about?

NCT03650101 is a clinical study titled "Improving Infant Hydrocephalus Outcomes in Uganda". Neonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ventriculostomy (ETV) ...

What is the current status of trial NCT03650101?

This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2021-05-05. Estimated completion is 2027-12.

What conditions does trial NCT03650101 study?

This clinical trial studies the following conditions: Hydrocephalus.

What interventions are being tested in trial NCT03650101?

The interventions under investigation include: ETV/CPC (PROCEDURE).

Who is sponsoring clinical trial NCT03650101?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03650101 being conducted?

This trial has 3 study locations across Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hydrocephalus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hydrocephalus

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.